Drug intelligence / Profile preview

unfermented isoflavone-enriched soybean leaves

Development stage
Preclinical
Administration
Oral
01

Overview

Unfermented isoflavone-enriched soybean leaves are a *plant-derived dietary product* characterized by their high concentration of **isoflavones**, a class of phytoestrogens predominantly present in soybeans and related soy foods[2][4]. Isoflavones such as genistein and daidzein in unfermented soy exist mostly in glycoside forms, which are less bioavailable compared to their aglycone forms found in fermented soy; consequently, unfermented products exhibit lower isoflavone aglycone bioavailability[3]. Isoflavones are noted for *anti-inflammatory*, *antioxidant*, and potential *anticancer* activities, primarily through inhibition of pro-inflammatory mediators (such as IL-1β, IL-6, TNF-α), regulation of oxidative stress enzymes (like superoxide dismutase, glutathione peroxidase), and modulation of transcription factors such as NF-κB and Nrf2[2]. They may also modulate estrogen receptor signaling due to their phytoestrogen properties. Isoflavones are under investigation in conditions including inflammatory diseases, cancer, and cardiovascular conditions, though concerns remain about potential carcinogenicity or endocrine effects at high doses[2][4]. These leaves are commonly used in nutritional research and as a natural medicine or supplemental health food rather than a pharmaceutical drug.

Other names
unfermented soybean leavesisoflavone-enriched soybean leaves
02

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on unfermented isoflavone-enriched soybean leaves.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on unfermented isoflavone-enriched soybean leaves.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call